Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Now thats an investor to invite to the bell ringing ceremony party in the future!!!!!!!! Lets hope we get there!
Some good points. I believe that the OEM's, Hospira, CareFusion, Smiths Medical will buy the products from RXSF for their infusion pumps and perhaps package them with new pump sales, and to replace in service pendants that fail (they have a 12 months life in a hospital and assisted living environment). But I also know that the company will not lose its brand identity either. In her last company, the CEO was able to get big brand names on her products - MasterLock, Overhead Door Company, Honeywell, etc......and she will probably take the same path here. They are all brand names, they already have millions of units in the market, they have established distribution channels, and RXSF offers a more secure, more efficient product that is an "add-on" to the actual infusion pumps themselves. I understand the product is infusion pump agnostic, so its universal and works with all of them. It just replaces the patient controlled "pendant" which is a medical term for a simple switch. This CEO is very brand sensitive and I am sure if those huge established companies buy this product, the product itself with have a RXSF marking in it somewhere. Same with the MyDOSE product, the difference being is while RXSF manufacturers both the SafeDOSE and MyDOSE products, the MyDOSE needs to be packaged with a major pharma company to meet FDA requirements. So, who has a secure injector? NO ONE! How many big pharma companies are getting their heads bashed in by the FEDS, the FDA and patient user lawsuits - all because these drugs are dangerous? How big a stretch is it for big pharma to want this product, at minimum for great PR, at best, to save millions in lawsuits, to meet compliance requirements and to further take measures to secure controlled substances.
So there really is a HUGE picture here for RXSF in the medical device market - dwarfing the retail safe side. Consumer and professional healthcare secure access and control of controlled substances - you couldn't write a more perfect script for the future IMHO.
Plus I am sure there are new products in the works as well.
Yea Cheeky - he needs to read more - he thinks this is a consumer products company. Go back to the biotech company example and maybe the bigger picture will materialize. The BIG money has nothing to do with the safes - that just the "feel good" story the company has that those institutional firms balance the business serious medical device picture with. Its easy to use the consumer product to make its point and use of its technology because there is a lot of emotion on the consumer side dealing with drug abuse. Those big institutional lenders invest that kind of money into medical device companies - not consumer-focused retail product companies. Its more about drug diversion and securing and controlling how controlled substances are dispensed. Thats the message I get from the company and its CEO anyway.
I understand. Risk is risk, and mitigating risk is what trading is all about. So, would you invest in a biotech firm that has just started developing a new drug - doesn't even have a product yet, hasn't gone through Phase 1 clinical trials? Hundreds of millions of dollars are invested into those companies on a prayer and a hope - and its not day traders. Its old school institutional investors, venture capital and hedge funds. Then comes the medical device companies - same story.
If you have been following RXSF you would see that this is a medical device company - not a consumer product play that lives or dies by retail. Although it has huge retail potential for its consumer safe product, that program was just announced last month, and it seems it hasn't really started yet - I am sure we will hear from CVS when it does.
So while you are right, the indicators some are looking for are just starting to develop, and others are more irrelevant as to the companies huge medical device products, its something you will have to go back and examine the disclosures since the summer. The CEO is transparent that way. She states a plan and objective, tells us why, and we watch her execute. If you're long, your comfortable with that. If your not, you search for minutia to back fill a smaller picture. Nothing wrong with that at all, but I am hoping both shorts and longs can make out together on this company.
If you refuse to answer when you ordered, and start spewing a whole bunch of nonsense regarding "metrics" based on delivery times - your explanations leave a LOT to be desired.
Some of you IHUB day traders really think you can outwit companies, and CEO's, and that you can pry out information to use in your buying and selling patterns.
Here is some advice - unlike other company's you need to "test" in order to find out the information you are looking for - CALL LORRAINE YARDE - she answers all customer and shareholder questions, and if she can legally tell you what you need to learn, she will.
To the chagrin of some - not everything is in the numbers - call her. Easy as that.
I am sure when the company actually announces the CVS program, some of this information will be forthcoming. From what I know, it hasn't even started yet.
OK, good, WHEN did you order this? Just curious. Mine took 4 business days to arrive.
When did you order this?
If you "ordered" a unit through CVS, you would have received confirmation of your order immediately from CVS's website via email like we all did. Show us your email confirmation -
Correct. I have spoken to the CEO about that company. That company makes computerized robotic automated pharmacy fulfillment systems. It has no connection to RXSF, distributes through different markets, targets different customers....and uses completely different technology that is all computer based and robotic. That company also plays in a very crowded market..........BUT, the two companies know each other and have been speaking with each other. Thats all I know.
Releasing sales figures before they are audited would be reckless. It does nothing but feed the market partial information without including costs, etc......A lot of companies do that because the day traders feed off of that, and you MUST know that. And your grass roots mentality is whats causing you to not see that this is that "OTHER" kind of company. This is obviously not the way YOU would run things, and quite frankly, no one here, or involved with the company actually cares.
But lets correct some of your ....misstatements....again. The company did NOT acquire a lapsed patent. It was revived by the owner before it was sold to the company. Why they let it lapse ask them. Thats irrelevant in any book. Projections of $150M are based on detailed pro-forma's and are just that - oh, and part of an SEC disclosure. The company filed an 8K that included the projections in one of its financial projections slides. So it IS and based on an SEC filing.
Right now, you are about 2 quarters ahead of yourself.. As much as you want numbers, you will just have to wait like the rest of us for the Q and the K. The only REAL numbers now is all about funding and how that will be structured. If you are relying on selling safes and safe sales (which is very small minded - no offense intended), you are most definitely missing the picture, and the market real funders fund on.
It reminds me of someone who approached a friend of mine with a gimmicky crappy product called Gimme Twenty - wasted a lot of peoples time and that CEO failed because he was very small minded and really had no clue how the big boys do things, what they really look for (opportunity). Then he tried to take another companies product from them and compete. Another very pathetic attempt. I am sure you are not like that.You seem to have skills. Expand your box.
Its what all companies do...they project revenues. Thats what all development stage companies do. We understand that you are only a fundamentals driven guy, and actually, that works for the HUGE well funded companies, as well as the mom and pop shops like your own. Won't argue with you there. Again, its too early to see what you demand to see - not a single positive comment in over 2000 pots from you - so we aren't expecting to change your tune anytime soon. There is a whole other side in the investment industry that has a whole different analysis they apply when investing into a development stage/market emerging company.
I wonder if Hokie was right about you. That would explain everything.
Wow, YD shows up, the stock is walked down. I wish it were a coincidence.
Need to be careful with hemp. There is a LOT of hype created by experienced stockbrokers and traders, who are also running the conventions. Look at MJMJ and MDBX fall from grace. The problem is money. Venture obey runs out, and no bank lends to them. Why, because it still violates federal law. Banks aren;t allowed to lend to those businesses. So its solely up to the speculators. Almost every hemp company is down, whether its growers, harvesters, dispensaries, resorts, etc...... The hemp foods are just starting to be banned by certain states that approved medical MJ use.
Thats a tough industry, highly speculative, and has a huge enemy right now. Uncle Sam.
I think RXSF makes a pot safe as well!
Glad to hear that. I enjoy a lot of your posts. Cheers!
Notice the big bid at $4.50. I would guess thats theie sweet spot to cover. I would guess anything over $5.00 on average, they lose money. Thats why NITE hasn't moved off that bid and ask.
Its fine, I think your probably a very good trader, and knew all that already. I'm on my second glass, so no offense, please.
Theres math, and theres common sense. And sometimes its a little of both. Not going to run a technical analysis now, going to enjoy the baby Amarone I have in my hand right now. The stock is shooting up because the guy at NITE, sitting n the trading desk can't find any stock to fill. It doesn't exist right now. Big Ask to block the market, big bid to force sales and cover. Not rocket science.
I expect to see MM desparation starting today. That 4,000 Ask, yea, doesn't exist. Its there to block the upswing. They will take their chances on locking up the market over filling such a mystical huge order. In the meantime, the huge bid amounts tell the real tale. Remember, its still day traders V. MM's today. Until monday. Do you know a day trader that will ever trade like that on Christmas Eve?
TFN - guess you really don't know this business as much as you think you might. Level II shows all, if you know how to read it and follow the facts.
SHORT is EXPOSED with that 4200 shares bid at $4.50!!!!!
And theres no retail around until monday! Imagine when they show up monday!
1 share at $8.99? MM desperate, LOL
Actually TFN - Cheeky is unfortunately 150% correct about that. Last year, the company made a misstep and got involved with several former "defrocked" brokers, who were consultants to the company before it became public. Some of them hid that fact while others promised the moon - (just like every defrocked broker who turns into a "consultant for an OTC company) It's well documented by the company in its disclosures and releases. Two were in particular doing IR (or complete lack of IR). Based on the information I was able to come up with, it looked like one of those "groups" wanted the share price to tank so its friends could pick a huge chunks of stock extremely dirt cheap, and then use those shares as leverage to try to take the company away. According to my sources, there were at least 2 attempts to force her out so they could take over, and when those failed, they offered the founders $1M to buy them out. It was a good try, because with a stock price of .0025, the company could not attract good capital, and could not do any other deals using stock as consideration.
And this started happening in March, when Lorraine spurned the first attempt. Obviously a LOT of people see tremendous value in this company, and she undertook this restructuring and rebranding in accordance with her shareholder letter.
Had you read the disclosures and press releases and the shareholder letter, as well as tidbits of her conversations with shareholders on this board, you too would see this. All the more reason to support her. She outflanked pretty smart people and has set up the company to thrive in 2016.
And she has the bite of a T-Rex....watch out!!!!!
It's more fun to trade for dollars.
FYI - retail is out today, so its MM' v day traders for next few days. They will be back monday I am sure! Just heard from my guy. Not enough stock in DT hands to cover - should get very interesting by early next week.
Unless its a painted pony!
They have their own bids in the $3's to give them room to move up if no one sells into them. They have a LOT to cover. If you don't believe me, watch over the next week. You can pretend its not short.
Paid dumper? Development stage company's rarely have revenues at this level. Gurufocus? What a F'n joke THAT is. Just another self generating IR BS pump and dump firm disguised as research, LOL. Probably paid you to help them tank this, because you showed up right after the run - go tell you boss - unfortunately I think they aren't getting the stock they thought they were - so they better cover now. Day 3 started today.
You better go reread a lot of the posts.
LMAO. This is exactly what I mean - man- someone MUST be very short!
Throwing up negatives and positives will do nothing to expedite the desired results from this company. It may make the stock more volatile and that seem to be the motive here. The company is moving along and has been doing what it says it will been doing, notwithstanding anyone else's opinion here - because opinions are like.....well, you know the saying. Its ALL speculation - but remember, most health-related/biotech firms that go from the OTC to NASDAQ have no actual product and no revenues. They move up exchanges to get more sophisticated eyeballs and attract big money to fund their business models and the development of their products. If you want to invest in fundamentals, wait to see if this company uplifts and performs, because saying you invest in fundamentals at this level, is a complete joke. Investments are made on either what if's, or whats done. Here, we are right in the middle. Forecasting is a huge part of any public company, so to say the CEO's forecasts mean nothing, then you completely missed the boat, or, are just too early to participate.
More money is invested at much higher levels into companies that can make a difference in healthcare, whether it is a new drug formulary, or a new medical device, and that those companies products address huge health and monetary issues. IMHO, CVS, McKesson, the safe product, are all but stepping stones to a much bigger game. I realize this, its a shame that so many people here are short-sighted.
I can tell this is shorted big time, no matter what analysis you want to put into play, painting on 1 trade on a $1.40 spread, flipping, shorting report sites are not credible, no revenues report yet - all of what the company is doing takes time - and while some of you want to distract from the companies progress, it doesn't change the fact that the company HAS and continues to make progress.
Look, this is like a fine bottle of Bertani Amarone. Its been sitting in the cabinet for a few years because you forgot it was there and your guests didn't even know it existed. Now, you just uncorked it, put it into the decanter, and you have to let it breathe for a while. The aroma is just starting to attract guests. I would like to see instant results, as would YD, TFN and several other posters following this stock - but JEEZ - its freakin' XMAS - people aren't looking at stocks now except the MM trying to make their last few cents for the year. 1st Q 2016 IMHO is going to be huge for all of us. Right now, we need to let it breathe before we sip the fine nectar.
Hopefully Lorraine will conduct the year end toast - "Peace on Earth, good will to RXSF IHUBBERS - may your glasses be full, your aspirations long, and your rewards plentiful!!!!".
EXCEPT YOU POS MM'S
So let me get this straight, you came in and posted "paid pump", obviously in an effort to scare traders and discredit the company, then bought low after the stock went down under $5.00. OR, after you posted "paid pump", helping the stock drop a few dimes, THEN picked up shares on the scare? I just want everyone here to know this.
Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies for investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.
You decide.
I am sure if they hired BMO it would be disclosed. BUT, it seems to be a very BIG and well known company on the big board as well. Either way it seems good.
I am sure it will. Just remember, every time you show up, the company;s market cap drops - and I am guessing its no coincidence. Or is it.
And some investors don't, and you are correct, but most small companies, especially the biotech companies have no revenues, and are all driven by hope that their new formulary's will get FDA approval and work. No different here other than the funding, and for all accounts, this CEO has delivered on everything she said she would - and its about 1Q too early for a sales revelation, no matter how hard you keep beating that drum, although I am sure, you will see sales numbers when the next Q or K come out. Its just that simple. Too early to reveal anything without establishing the foundation first - and, the in-store CVS program hasn't even started yet - or I am sure you would have seen news out. Just the same old paid story from you.